Information:
Fel:
Nyckelord
Inflamación Experimental del Pulmón ×
- Clinical Trial (25)
- Pneumococcal Vaccines (20)
- Otitis Media (20)
- Vaccination (6)
- Adverse event (6)
- Routine documentation (6)
- Pulmonary Medicine (5)
- Asthma (4)
- Eligibility Determination (4)
- Community-Acquired Infections (3)
- Classification (3)
- Bacterial Infections (2)
- Clinical Trial, Phase III (2)
- Pulmonary Disease, Chronic Obstructive (2)
- EHR (2)
- Concomitant Medication (2)
- Chest X- ray (2)
- Glucocorticoids (2)
- Laboratories (2)
- Patient Admission (2)
- Physical Examination (1)
- Professional-Family Relations (1)
- Random Allocation (1)
- Risk Factors (1)
- Seizures (1)
- Signs and Symptoms (1)
- Steroids (1)
- Universal Precautions (1)
- Blood (1)
- Acute Disease (1)
- Cerebrovascular Disorders (1)
- Vital Signs (1)
- Adrenergic beta-2 Receptor Agonists (1)
- Dry Powder Inhalers (1)
- Healthy Volunteers (1)
- Treatment Form (1)
- End of Study (1)
- Quality Assurance (1)
- Drug trial (1)
- Released Standard (1)
- Clinical Protocols (1)
- Demography (1)
- Endocrine System Diseases (1)
- Eye Diseases (1)
- Infection (1)
- Lung (1)
- Medical History Taking (1)
- Medical Records (1)
- Meningitis (1)
- Metabolism (1)
- Nasopharynx (1)
- Organization and Administration (1)
- Patient Compliance (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
35 Sökresultat.
Item-grupp: pht003623
pht003624.v1.p1
1 Item-grupp 5 Dataelementpht003625.v1.p1
1 Item-grupp 2 Dataelementpht003626.v1.p1
1 Item-grupp 5 Dataelement Item-grupper: Characteristics, Risk factors for Risk Group 1 (Tab.1), Classification
Item-grupp: CURB-Index
Item-grupp: CRB-65-Index
Item-grupper: Administrative data, X Ray Pneumonia Confirmation (X-ray)
Item-grupper: Administrative data, ELIMINATION CRITERIA DURING THE STUDY, WARNINGS AND PRECAUTIONS, Precautions specific to Diphteria, Tetanus and Pertussis (DTPa) vaccine administration, CONTRAINDICATIONS TO SUBSEQUENT VACCINATION, Absolute contraindication to administration of DTPa-HBV-IPV/Hib or DTPa-IPV/Hib, EXCLUSION CRITERIA FOR FURTHER STUDY PARTICIPATION
Item-grupp: Chest X-Ray
Item-grupper: Cardiac Disorders, Endocrine Disorders, Eye Disorders, Vascular Disorders, Metabolism and Nutrition Disorders, Infections and Infestations
Item-grupper: Date of Visit/ Assessment, Adverse Event/ Concomitant Medication/ Repeat Assessment Check Questions, Non- serious Adverse Event, Serious Adverse Event, Relevant medical conditions/ risk factors, Relevant Concomitant/ Treatment Medications, Relevant Diagnostic Results, Investigational Product, General Narrative Comments, Concomitant Medication, Electronically transferred lab data, Vital signs , 12- Lead ECG, ECG Abnormalities, Pharmacodynamics - Cortisol , Pharmacodynamics Results - Glucose, Pharmacodynamics Results - Potassium, Pharmacokinetics Blood - FF/GW642444M , Defective Inhaler, X Ray Pneumonia Confirmation
Item-grupper: Administrative data, CONCOMITANT VACCINATION, MEDICATION
Item-grupper: Administrative data, CONVULSION EPISODE
Item-grupper: Administrative data, NON-SERIOUS ADVERSE EVENTS, AE Number